Reference Spotlight
Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy
Announcement
As of January 1st, 2020 the KinExA 3000 will no longer be supported. Preventative maintenance agreements purchased before 2020 will be honored until expiration but will not be eligible for renewal. This will not impact KinExA 3200 or 3100 users.
As of January 1st, 2020 the KinExA 3000 will no longer be supported. Preventative maintenance agreements purchased before 2020 will be honored until expiration but will not be eligible for renewal. This will not impact KinExA 3200 or 3100 users.